Terns Pharmaceuticals Inc (TERN)
5.79
+0.08
(+1.40%)
USD |
NASDAQ |
Nov 22, 16:00
5.79
0.00 (0.00%)
After-Hours: 20:00
Terns Pharmaceuticals Cash from Investing (Quarterly): 31.75M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 31.75M |
| June 30, 2024 | 42.19M |
| March 31, 2024 | 7.997M |
| December 31, 2023 | 47.23M |
| September 30, 2023 | -22.31M |
| June 30, 2023 | -90.84M |
| March 31, 2023 | 27.93M |
| December 31, 2022 | -14.55M |
| September 30, 2022 | -1.24M |
| June 30, 2022 | -15.97M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.488M |
| December 31, 2021 | -6.421M |
| September 30, 2021 | 4.443M |
| June 30, 2021 | -20.90M |
| March 31, 2021 | -96.82M |
| December 31, 2020 | -0.047M |
| September 30, 2020 | -0.005M |
| June 30, 2020 | -0.102M |
| March 31, 2020 | 6.847M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-96.82M
Minimum
Mar 2021
47.23M
Maximum
Dec 2023
-4.806M
Average
-0.047M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Viking Therapeutics Inc | 25.90M |
| Biomarin Pharmaceutical Inc | -16.16M |
| Elite Pharmaceuticals Inc | 0.0176M |
| Verrica Pharmaceuticals Inc | -0.016M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -16.46M |
| Cash from Financing (Quarterly) | 163.29M |
| Free Cash Flow | -74.83M |
| Free Cash Flow Per Share (Quarterly) | -0.2115 |
| Free Cash Flow Yield | -17.29% |